Medtronic (MDT) Cash from Investing Activities (2014 - 2026)

Medtronic has disclosed Cash from Investing Activities across 13 years of filings, most recently posting -$1.6 billion for Q3 2026.

• In Q3 2026, Cash from Investing Activities fell 125.17% year-over-year to -$1.6 billion; the TTM figure through Jul 2026 stood at -$3.8 billion (down 59.95% YoY), while the FY2026 annual figure was -$2.9 billion, down 51.47% from the prior year.
• Cash from Investing Activities came in at -$1.6 billion for Q3 2026 at Medtronic, down from -$917.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $271.0 million in Q2 2022 to a low of -$1.6 billion in Q3 2026.
• Average Cash from Investing Activities over 5 years is -$658.7 million, with a median of -$539.0 million recorded in 2023.
• Year-over-year, Cash from Investing Activities soared 84.24% in 2022 and sank 275.28% in 2023.
• Over 5 years, Cash from Investing Activities stood at -$1.1 billion in 2022, then surged by 63.0% to -$424.0 million in 2023, then increased by 18.63% to -$345.0 million in 2024, then sank by 39.71% to -$482.0 million in 2025, then plunged by 235.89% to -$1.6 billion in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$1.6 billion in Q3 2026, -$917.0 million in Q2 2026, and -$816.0 million in Q1 2026.